Development Level

Tbio 18 | 11,445
Tdark 3 | 6,588

IMPC Phenotype

abnormal behavior 2 | 298
decreased circulating insulin ... 2 | 76
decreased total body fat amoun... 2 | 207
embryonic lethality prior to t... 2 | 278
increased total body fat amoun... 2 | 134
preweaning lethality, complete... 2 | 979
abnormal embryo size 1 | 220
abnormal eye morphology 1 | 68
abnormal gait 1 | 69
abnormal heart morphology 1 | 162
abnormal pericardium morpholog... 1 | 26
abnormal response to new envir... 1 | 10
abnormal response to tactile s... 1 | 17
abnormal sleep behavior 1 | 70
abnormal thymus morphology 1 | 7
alopecia 1 | 1
decreased IgE level 1 | 6
decreased body weight 1 | 161
decreased bone mineral density 1 | 126
decreased circulating HDL chol... 1 | 68
decreased circulating alkaline... 1 | 46
decreased circulating chloride... 1 | 30
decreased circulating choleste... 1 | 93
decreased circulating creatini... 1 | 39
decreased circulating glucose ... 1 | 126
decreased circulating lactate ... 1 | 3
decreased large unstained cell... 1 | 11
decreased lymphocyte cell numb... 1 | 83
edema 1 | 59
embryonic growth retardation 1 | 106
embryonic lethality prior to o... 1 | 239
enlarged heart 1 | 210
hydrometra 1 | 53
hyperactivity 1 | 148
increased blood urea nitrogen ... 1 | 48
increased bone mineral content 1 | 108
increased bone mineral density 1 | 72
increased circulating chloride... 1 | 41
increased circulating creatini... 1 | 38
increased circulating glucose ... 1 | 24
increased circulating serum al... 1 | 22
increased erythrocyte cell num... 1 | 39
increased exploration in new e... 1 | 8
increased grip strength 1 | 41
increased heart weight 1 | 62
increased lean body mass 1 | 172
limb grasping 1 | 41
mammalian phenotype 1 | 17
preweaning lethality, incomple... 1 | 499
small superior vagus ganglion 1 | 74
small thymus 1 | 16
tremors 1 | 39
trunk curl 1 | 16

Disease

medulloblastoma, large-cell 13 | 6,241
ovarian cancer 12 | 8,520
Carcinoma 10 | 11,493
osteosarcoma 8 | 7,950
psoriasis 8 | 6,694
atypical teratoid / rhabdoid tumor 7 | 5,112
ependymoma 7 | 4,679
glioblastoma 7 | 5,792
group 3 medulloblastoma 7 | 4,104
Pick disease 6 | 1,894
non-small cell lung cancer 6 | 2,890
oligodendroglioma 6 | 2,850
Astrocytoma, Pilocytic 5 | 3,081
Hypomyelinating leukodystrophy 6 5 | 26
astrocytic glioma 5 | 2,597
invasive ductal carcinoma 5 | 2,951
lung adenocarcinoma 5 | 2,716
malignant mesothelioma 5 | 3,232
Breast cancer 4 | 3,578
adult high grade glioma 4 | 3,801
ductal carcinoma in situ 4 | 1,745
group 4 medulloblastoma 4 | 1,855
lung cancer 4 | 4,740
lung carcinoma 4 | 2,843
Diarrhea 3 | 253
breast carcinoma 3 | 1,638
dermatomyositis 3 | 966
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,955
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
juvenile dermatomyositis 3 | 1,187
pancreatic cancer 3 | 2,398
pancreatic carcinoma 3 | 562
spina bifida 3 | 1,074
tuberculosis 3 | 2,010
Anemia 2 | 365
Autosomal recessive predisposition 2 | 1,442
Colitis 2 | 54
Epilepsy 2 | 792
Familial hemophagocytic lymphohistiocytosis 4 2 | 2
Gastroenteritis 2 | 41
Kidney Failure 2 | 111
Osteogenesis imperfecta type 15 2 | 3
Pancreatic agenesis 2 | 17
Schizophrenia 2 | 1,160
Tetanus 2 | 68
active Crohn's disease 2 | 922
acute quadriplegic myopathy 2 | 1,158
adrenocortical carcinoma 2 | 1,428
axial spondyloarthropathy 2 | 28
colon cancer 2 | 1,478
cystic fibrosis 2 | 1,696
diabetes mellitus 2 | 1,728
interstitial cystitis 2 | 2,312
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,962
pituitary cancer 2 | 1,972
primitive neuroectodermal tumor 2 | 3,035
progressive supranuclear palsy 2 | 676
subependymal giant cell astrocytoma 2 | 2,287
ulcerative colitis 2 | 1,819
Autistic Disorder 1 | 364
Botulism 1 | 24
CEROID LIPOFUSCINOSIS, NEURONAL, 6 1 | 6
COPD 1 | 118
Cataract 8 multiple types 1 | 33
Chediak-Higashi syndrome 1 | 26
Decreased antibody level in blood 1 | 35
Defective enamel matrix 1 | 35
Dental Enamel Hypoplasia 1 | 43
Disease of anatomical entity 1 | 32
Dysplasia of tooth enamel 1 | 35
Fever 1 | 138
Glaucoma, Open-Angle 1 | 11
Griscelli syndrome type 2 1 | 12
Hermansky-Pudlak syndrome 1 | 42
Hyperphosphatemia 1 | 32
Hypogammaglobulinemia 1 | 35
Hypohidrosis 1 | 34
Immunologic Deficiency Syndromes 1 | 113
Isolated cases 1 | 72
Lambert-Eaton myasthenic syndrome 1 | 12
Late tooth eruption 1 | 61
Malabsorption 1 | 82
Microvillus inclusion disease 1 | 8
Neuronal ceroid lipofuscinosis 8 northern epilepsy variant 1 | 6
Pancytopenia 1 | 45
Pseudohypoaldosteronism 1 | 23
Recurrent respiratory infections 1 | 141
Round face 1 | 45
Round, full face 1 | 45
Thin dental enamel 1 | 35
Thrombocytopenia 1 | 197
Typhoid fever 1 | 22
Vici syndrome 1 | 14
Visual epilepsy 1 | 4
Vitiligo 1 | 73
Williams-Beuren syndrome 1 | 50
cystic fibrosis and chronic rhinosinusitis 1 | 214
interstitial lung disease 1 | 298
sarcoidosis 1 | 370

Tissue

Blood and immune system 21 | 16,909
Digestive Tract 21 | 17,369
Endocrine System 21 | 18,159
Female tissues 21 | 17,400
Liver and Pancreas 21 | 16,750
Male tissues 21 | 17,142
Nervous System 21 | 16,725
Respiratory system 21 | 16,393
Skin and soft tissues 21 | 17,230
Urinary Tract 21 | 16,678
Cardiovascular System 19 | 15,192

Target Family

Non-IDG 21 | 12,091

GO Process

vesicle docking 21 | 21
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Protein NDRG4 NDRG4 Tbio Non-IDG -1.46835 37.8 195
Syntaxin-8 STX8 Tbio Non-IDG -2.59234 391.5 134
Caveolin-2 CAV2 Tbio Non-IDG -2.43448 254.2 294
Syntaxin-10 STX10 Tbio Non-IDG -1.14573 14.1 92
Exocyst complex component 5 EXOC5 Tbio Non-IDG -1.45220 28.7 83
Syntaxin-2 STX2 Tbio Non-IDG -2.93775 902.6 197
Syntaxin-17 STX17 Tbio Non-IDG -1.51185 33.1 109
Syntaxin-4 STX4 Tbio Non-IDG -1.95295 84.2 207
Centrosomal protein of 83 kDa CEP83 Tdark Non-IDG -0.47180 2.89 0
Syntaxin-12 STX12 Tbio Non-IDG -1.09934 11.4 124